India to Poland: Sofosbuvir Export Trade Route
India has recorded 87 verified shipments of Sofosbuvir exported to Poland, representing a combined trade value of $3.6M USD. This corridor is served by 7 active Indian exporters, with an average shipment value of $41.8K USD. The leading Indian exporter is MYLAN LABORATORIES LIMITED , which accounts for 87% of total export value with 3 shipments worth $3.2M USD. On the buying side, STATE ENTERPRISE UKRVAKTSYNA is the largest importer in Poland with $1.6M USD in purchases. The top 3 suppliers — MYLAN LABORATORIES LIMITED , EURO LIFECARE PRIVATE LIMITED, MYLAN LABORATORIES LIMITED — together control 97% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Poland Sofosbuvir corridor is one of India's established pharmaceutical export routes, with 87 shipments documented worth a combined $3.6M USD. The route is dominated by MYLAN LABORATORIES LIMITED , which alone accounts for roughly 87% of all export value, reflecting the consolidated nature of India's sofosbuvir manufacturing sector.
Across 7 active suppliers, the average shipment value stands at $41.8K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (68%) and air (17%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.
Shipment activity peaks during April–June, with an average transit time of 26 days port-to-port. The route has recorded an annual growth rate of 12.6%, placing it at rank #5 among India's top sofosbuvir export destinations globally.
On the import side, key buyers of Indian sofosbuvir in Poland include STATE ENTERPRISE UKRVAKTSYNA , STATE ENTERPRISE UKRVAKTSYNA, , OST WEST EXPRESS and 18 others. STATE ENTERPRISE UKRVAKTSYNA is the single largest importer with 1 shipments valued at $1.6M USD.
Route Characteristics
- Average transit26 days
- Peak seasonQ2
- Primary modeMulti-modal
- Top portAHEMDABAD AIR
Market Position
- Global rank#5
- Annual growth+12.6%
- Demand growth+11.1%
- Regulatory ease68/100
Top 10 Indian Sofosbuvir Exporters to Poland
Showing top 10 of 7 Indian suppliers exporting Sofosbuvir to Poland, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | MYLAN LABORATORIES LIMITED Avg $1.1M per shipment | 3 | $3.2M | 86.7% |
| 2 | EURO LIFECARE PRIVATE LIMITED Avg $96.8K per shipment | 2 | $193.6K | 5.3% |
| 3 | MYLAN LABORATORIES LIMITED Avg $32.5K per shipment | 5 | $162.5K | 4.5% |
| 4 | LEOWIN HEALTHCARE LLP Avg $1.9K per shipment | 57 | $107.7K | 3.0% |
| 5 | HEET HEALTHCARE PRIVATE LIMITED Avg $959 per shipment | 13 | $12.5K | 0.3% |
| 6 | SACRED LEAVES PRIVATE LIMITED Avg $1.3K per shipment | 4 | $5.4K | 0.1% |
| 7 | SACRED LEAVES PRIVATE LIMITED Avg $425 per shipment | 3 | $1.3K | 0.0% |
This table shows the top 10 of 7 Indian companies exporting sofosbuvir to Poland, ranked by total trade value. The listed exporters are: MYLAN LABORATORIES LIMITED , EURO LIFECARE PRIVATE LIMITED, MYLAN LABORATORIES LIMITED, LEOWIN HEALTHCARE LLP, HEET HEALTHCARE PRIVATE LIMITED, SACRED LEAVES PRIVATE LIMITED, SACRED LEAVES PRIVATE LIMITED . MYLAN LABORATORIES LIMITED is the dominant supplier with 3 shipments worth $3.2M USD, giving it a 87% market share. The top 3 suppliers together account for 97% of the total trade value on this route.
Top 10 Sofosbuvir Importers in Poland
Showing top 10 of 21 known buyers in Poland receiving Sofosbuvir shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian sofosbuvir in Poland include STATE ENTERPRISE UKRVAKTSYNA , STATE ENTERPRISE UKRVAKTSYNA, , OST WEST EXPRESS, TO THE ORDER, ICF ALLIANCE FOR PUBLIC HEALTH, among 21 total buyers. The largest importer is STATE ENTERPRISE UKRVAKTSYNA , accounting for $1.6M USD across 1 shipments — representing 43% of all sofosbuvir imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | STATE ENTERPRISE UKRVAKTSYNA | 1 | $1.6M | 42.8% |
| 2 | STATE ENTERPRISE UKRVAKTSYNA, | 1 | $1.6M | 42.8% |
| 3 | OST WEST EXPRESS | 1 | $128.1K | 3.5% |
| 4 | TO THE ORDER | 42 | $81.0K | 2.2% |
| 5 | ICF ALLIANCE FOR PUBLIC HEALTH | 2 | $69.0K | 1.9% |
| 6 | SPS PHARMA LLC | 1 | $65.5K | 1.8% |
| 7 | CHARITABLE ORGANIZATION ALL UKRAIN | 2 | $59.5K | 1.6% |
| 8 | ICF "ALLIANCE FOR PUBLIC HEALTH", | 1 | $41.1K | 1.1% |
| 9 | PUBLIC HEALTH CENTER OF THE | 1 | $33.9K | 0.9% |
| 10 | TO THE ORDER.. | 6 | $17.2K | 0.5% |
Showing top 10 of 21 Sofosbuvir importers in Poland on this route.
Top 10 Sofosbuvir Formulations Imported by Poland
Showing top 10 of 71 product formulations shipped on the India to Poland Sofosbuvir route, ranked by trade value
Poland imports a wide range of sofosbuvir formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — SOFOSBUVIR 400MG + VELPATASVIR 100MG TAB — accounts for $3.1M USD across 2 shipments. There are 71 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | SOFOSBUVIR 400MG + VELPATASVIR 100MG TAB | 2 | $3.1M | 85.6% |
| 2 | VELPANAT film coated tablets of 400 mg 100 mg 28 film coated tablets in a bottle SOFOSBUVIR AND VELPATASVIR 400mg 100mg | 1 | $128.1K | 3.5% |
| 3 | VELPANAT-film-coated tablets of 400 mg/100 mg 28,film-coated tablets in a bottle(SOFOSBUVIR AND VELPATASVIR 400mg/100mg) | 1 | $65.5K | 1.8% |
| 4 | DACLATASVIR 60 MG SOFOSBUVIR TABLETS 400 MG TAB 28S PACKS 28S BOTTLE 1665 PACKS X28S 46620 NOS | 1 | $42.6K | 1.2% |
| 5 | SOFOSBUVIR 400 MG + DACLATASVIR 60 MG 28 | 1 | $41.1K | 1.1% |
| 6 | SOFOSBUVIR 400 MG DACLATASVIR 60 MG 28TABLETS 1500 PACKS X 28S 42000 NOS | 1 | $40.7K | 1.1% |
| 7 | SOFOSBUVIR 400MG + VELPATASVIR 100MG TABLETS (28S) - MYHEP ALL (585 PACKS X 28S BOTTLE = 16380 NOS) | 1 | $33.9K | 0.9% |
| 8 | SOFOSBUVIR 400 MG AND VELPATASVIR 100 MG 28 TABLETS PACKS 28S BOTTLE 450PACKS X 28S=12600 NOS | 1 | $28.3K | 0.8% |
| 9 | SOFOSBUVIR 400 MG VELPATASVIR 100 MG TAB 28S PACKS 28S BOTTLE 285 PACKSX28S 7980 NOS | 1 | $17.0K | 0.5% |
| 10 | SOFOSBUVIR 400MG & VELPATASVIR 100MG TABLETS OTHER DETAILS AS PER INVOICENOS | 3 | $9.0K | 0.2% |
Showing top 10 of 71 Sofosbuvir formulations imported by Poland on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Balanced freight mix — 68% sea for bulk, 17% air for urgent orders.
Top Ports of Origin
AHEMDABAD AIR handles the highest volume with 31 shipments. Transit time averages 26 days by sea.
Market Dynamics
India's sofosbuvir exports to Poland are driven primarily by a handful of large-scale manufacturers. MYLAN LABORATORIES LIMITED with 3 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 7 active exporters signals a competitive but concentrated market — buyers in Poland benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — MYLAN LABORATORIES LIMITED , EURO LIFECARE PRIVATE LIMITED, MYLAN LABORATORIES LIMITED — together account for 97% of total trade value on this route. The average shipment value of $41.8K USD reflects a mix of bulk commercial orders and smaller specialty shipments.
Beyond the primary product category, shipments on this route include closely related formulations such as velpanat film coated tablets of 400 mg 100 mg 28 film coated tablets in a bottle sofosbuvir and velpatasvir 400mg 100mg and velpanat-film-coated tablets of 400 mg/100 mg 28,film-coated tablets in a bottle(sofosbuvir and velpatasvir 400mg/100mg), suggesting that buyers in Poland tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, STATE ENTERPRISE UKRVAKTSYNA is the largest importer with 1 shipments worth $1.6M USD — representing 43% of all sofosbuvir imports from India on this route. A total of 21 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $3.6M
- Avg. Shipment
- $41.8K
- Suppliers
- 7
- Buyers
- 21
- Transit (Sea)
- ~26 days
- Annual Growth
- +12.6%
Related Analysis
Other Sofosbuvir Routes
Unlock the Full India to Poland Sofosbuvir Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 87 shipments on this route.
Frequently Asked Questions — India to Poland Sofosbuvir Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Sofosbuvir to Poland?
The leading Indian exporters of Sofosbuvir to Poland are MYLAN LABORATORIES LIMITED , EURO LIFECARE PRIVATE LIMITED, MYLAN LABORATORIES LIMITED. MYLAN LABORATORIES LIMITED holds the largest market share at approximately 87% of total trade value on this route.
Q What is the total value of Sofosbuvir exports from India to Poland?
India exports Sofosbuvir to Poland worth approximately $3.6M USD across 87 recorded shipments. The average value per shipment is $41.8K USD.
Q Which ports does India use to ship Sofosbuvir to Poland?
The most active port of origin is AHEMDABAD AIR with 31 shipments. Indian exporters primarily use a mix of sea and air freight for this route, with 68% of shipments going by sea and 17% by air.
Q How long does shipping take from India to Poland for Sofosbuvir?
The average transit time for Sofosbuvir shipments from India to Poland is approximately 26 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during April–June.
Q Is the India to Poland Sofosbuvir trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 12.6% with demand growth tracking at 11.1%. The route is ranked #5 among India's top Sofosbuvir export destinations globally.
Q How many suppliers are active on the India to Poland Sofosbuvir route?
There are currently 7 active Indian suppliers exporting Sofosbuvir to Poland. The market is moderately concentrated with MYLAN LABORATORIES LIMITED accounting for 87% of total shipment value.
Q Who are the main importers of Sofosbuvir from India in Poland?
The leading importers of Indian Sofosbuvir in Poland include STATE ENTERPRISE UKRVAKTSYNA , STATE ENTERPRISE UKRVAKTSYNA, , OST WEST EXPRESS, TO THE ORDER, ICF ALLIANCE FOR PUBLIC HEALTH. STATE ENTERPRISE UKRVAKTSYNA is the largest buyer with 1 shipments worth $1.6M USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Poland export trade corridor identified from Indian Customs (DGFT) records for Sofosbuvir.
- 2.Supplier/Buyer Matching: 7 Indian exporters and 21 importers in Poland matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 87 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
87 Verified Shipments
7 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists